Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (254) 254
science & technology (228) 228
life sciences & biomedicine (219) 219
female (147) 147
male (141) 141
middle aged (115) 115
infectious diseases (107) 107
aged (100) 100
intraabdominal infections - microbiology (100) 100
adult (92) 92
intraabdominal infections - epidemiology (91) 91
surgery (90) 90
intraabdominal infections - drug therapy (86) 86
retrospective studies (67) 67
risk factors (67) 67
abdomen (65) 65
microbiology (65) 65
anti-bacterial agents - therapeutic use (63) 63
health aspects (53) 53
microbial sensitivity tests (52) 52
anti-bacterial agents - pharmacology (47) 47
treatment outcome (44) 44
mortality (43) 43
pharmacology & pharmacy (43) 43
aged, 80 and over (42) 42
prospective studies (41) 41
antibiotics (40) 40
infections (40) 40
medicine & public health (38) 38
adolescent (37) 37
incidence (36) 36
abscess (35) 35
intra-abdominal infection (35) 35
young adult (35) 35
analysis (34) 34
general & internal medicine (34) 34
intraabdominal infections (33) 33
sepsis (33) 33
postoperative complications - epidemiology (32) 32
drug resistance, bacterial (30) 30
intraabdominal infections - etiology (29) 29
patients (28) 28
hospitals (27) 27
intensive care units (27) 27
intraabdominal infections - complications (26) 26
care and treatment (25) 25
drug resistance (25) 25
enterobacteriaceae - drug effects (25) 25
biological and medical sciences (24) 24
epidemiology (24) 24
medical sciences (24) 24
infectious disease (23) 23
intraabdominal infections - diagnosis (23) 23
critical care medicine (22) 22
internal medicine (22) 22
intraabdominal infections - mortality (22) 22
research (22) 22
anti-bacterial agents - administration & dosage (21) 21
cross infection - microbiology (21) 21
intra-abdominal infections (21) 21
peritonitis (21) 21
abridged index medicus (20) 20
length of stay (20) 20
drug resistance, multiple, bacterial (19) 19
enterobacteriaceae infections - microbiology (19) 19
medicine (19) 19
escherichia coli - drug effects (18) 18
intensive care (18) 18
medical research (18) 18
pediatrics (18) 18
pneumonia (18) 18
abdominal surgery (17) 17
beta-lactams - pharmacology (17) 17
gastroenterology & hepatology (17) 17
research article (17) 17
urinary tract infections - microbiology (17) 17
child (16) 16
enterobacteriaceae - isolation & purification (16) 16
logistic models (16) 16
nosocomial infections (16) 16
pathogens (16) 16
prevalence (16) 16
prognosis (16) 16
time factors (16) 16
urinary tract infections (16) 16
antibacterial agents (15) 15
antimicrobial agents (15) 15
appendectomy - methods (15) 15
bacteria (15) 15
cohort studies (15) 15
drug therapy (15) 15
gram-negative bacteria - drug effects (15) 15
infection (15) 15
klebsiella pneumoniae - drug effects (15) 15
medicine, experimental (15) 15
studies (15) 15
surgical wound infection - epidemiology (15) 15
cross infection - drug therapy (14) 14
enterobacteriaceae (14) 14
ertapenem (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (283) 283
Spanish (4) 4
Chinese (3) 3
Portuguese (3) 3
French (2) 2
German (1) 1
Hungarian (1) 1
Norwegian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High prevalence of hypervirulent Klebsiella pneumoniae infection in China: Geographic distribution, clinical characteristics, and antimicrobial resistance
by Zhang, Yawei and Zhao, Chunjiang and Wang, Qi and Wang, Xiaojuan and Chen, Hongbin and Li, Henan and Zhang, Feifei and Li, Shuguang and Wang, Ruobing and Wang, Hui
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6115 - 6120
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Diabetes Mellitus - pathology | Prevalence | Prospective Studies | Klebsiella Infections - pathology | Humans | Middle Aged | Virulence | Male | Klebsiella pneumoniae - classification | Phylogeny | Multilocus Sequence Typing | Cross Infection - pathology | beta-Lactamases - genetics | Pneumonia, Bacterial - pathology | Gene Expression | Pneumonia, Bacterial - complications | Plasmids - metabolism | Cross Infection - microbiology | Diabetes Mellitus - epidemiology | Plasmids - chemistry | Bacteremia - epidemiology | Bacteremia - pathology | Neoplasms - epidemiology | Intraabdominal Infections - complications | Klebsiella pneumoniae - isolation & purification | Diabetes Complications | Cross Infection - complications | Bacteremia - microbiology | Neoplasms - complications | Klebsiella Infections - epidemiology | Klebsiella pneumoniae - genetics | Adult | Female | beta-Lactamases - metabolism | Cross Infection - epidemiology | Pneumonia, Bacterial - microbiology | Intraabdominal Infections - microbiology | Neoplasms - microbiology | Phylogeography | Bacteremia - complications | Bacterial Proteins - genetics | Serogroup | Klebsiella Infections - complications | Pneumonia, Bacterial - epidemiology | China - epidemiology | Klebsiella Infections - microbiology | Intraabdominal Infections - epidemiology | Diabetes Mellitus - microbiology | Intraabdominal Infections - pathology | Klebsiella pneumoniae - pathogenicity | Bacterial Proteins - metabolism | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: Report from an antimicrobial surveillance programme (2012-15)
by Pfaller, Michael A and Bassetti, Matteo and Duncan, Leonard R and Castanheira, Mariana
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1386 - 1395
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Penicillanic Acid - pharmacology | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Humans | Europe - epidemiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Intraabdominal Infections - epidemiology | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Urinary Tract Infections - epidemiology | Epidemiological Monitoring | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Israel - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - drug effects | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Cephalosporins - pharmacology | Penicillanic Acid - analogs & derivatives | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection
by Charlesnika T. Evans and Nasia Safdar
Clinical infectious diseases, ISSN 1058-4838, 5/2015, Volume 60, Issue suppl_2, pp. S66 - S71
costs | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Clostridium Infections - economics | United States - epidemiology | Prevalence | Humans | Risk Factors | Clostridium difficile | Cost of Illness | Treatment Outcome | Clostridium Infections - epidemiology | Skilled Nursing Facilities | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - adverse effects | Clostridium Infections - therapy | Clostridium Infections - mortality | Intraabdominal Infections - drug therapy | Cross Infection - epidemiology | Pathogens | Infectious diseases | Antibiotics | Drug resistance | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010–2013
by Chang, Ya-Ting and Coombs, Geoffrey and Ling, Thomas and Balaji, V and Rodrigues, Camilla and Mikamo, Hiroshige and Kim, Min-Ja and Rajasekaram, Datin Ganeswrie and Mendoza, Myrna and Tan, Thean Yen and Kiratisin, Pattarachai and Ni, Yuxing and Barry, Weinman and Xu, Yingchun and Chen, Yen-Hsu and Hsueh, Po-Ren
International journal of antimicrobial agents, ISSN 0924-8579, 2017, Volume 49, Issue 6, pp. 734 - 739
Infectious Disease | Gram-negative bacilli | Antimicrobial susceptibility | Intra-abdominal infection | Asia-Pacific region | Epidemiology | Extended-spectrum β-lactamase | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | Intraabdominal Infections - microbiology | Humans | Drug Resistance, Bacterial | Gram-Negative Bacteria - isolation & purification | Intraabdominal Infections - epidemiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Asia - epidemiology | Pacific Islands - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Abscess | Beta lactamases | Disease susceptibility | Health aspects | Antibacterial agents | Abdomen | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011
by Hawser, Stephen and Hoban, Daryl J and Badal, Robert E and Bouchillon, Samuel K and Biedenbach, Douglas and Hackel, Meredith and Morrissey, Ian
Journal of chemotherapy (Florence), ISSN 1120-009X, 04/2015, Volume 27, Issue 2, pp. 67 - 73
Susceptibility | Intra-abdominal infection | Ertapenem | Pharmacology & Pharmacy | Pathology | Oncology | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Cholecystitis - drug therapy | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Abdominal Abscess - drug therapy | Ascitic Fluid - microbiology | Drug Resistance, Bacterial | Cholecystitis - microbiology | Incidence | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Gram-Negative Aerobic Bacteria - drug effects | Drug Resistance, Multiple, Bacterial | Escherichia coli - growth & development | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Length of Stay | Klebsiella Infections - drug therapy | Global Health | Intraabdominal Infections - microbiology | Escherichia coli Infections - microbiology | Abdominal Abscess - epidemiology | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Intraabdominal Infections - epidemiology | Gram-Negative Aerobic Bacteria - growth & development | Abdominal Abscess - microbiology | Escherichia coli Infections - epidemiology | Gram-Negative Aerobic Bacteria - isolation & purification | Cholecystitis - epidemiology | Epidemiological Monitoring | Escherichia coli - isolation & purification | Cross Infection - microbiology | Gram-Negative Bacterial Infections - epidemiology | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: Evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections
by Koksal, Iftihar and Yilmaz, Gurdal and Unal, Serhat and Zarakolu, Pinar and Korten, Volkan and Mulazimoglu, Lutfiye and Tabak, Fehmi and Mete, Birgul and Oguz, Vildan Avkan and Gulay, Zeynep and Alp, Emine and Badal, Robert and Lob, Sibylle
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1364 - 1372
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Enterobacteriaceae - isolation & purification | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Carbapenems - pharmacology | Escherichia coli - pathogenicity | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Intensive Care Units | Intraabdominal Infections - microbiology | Enterobacteriaceae - pathogenicity | Amikacin - pharmacology | Imipenem - pharmacology | Intraabdominal Infections - epidemiology | Urinary Tract Infections - epidemiology | beta-Lactams - pharmacology | Turkey - epidemiology | Escherichia coli - isolation & purification | Klebsiella pneumoniae - pathogenicity | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China
by Liu, Jiao and Zhang, Lidi and Pan, Jingye and Huang, Man and Li, Yingchuan and Zhang, Hongjin and Wang, Ruilan and Zhao, Mingyan and Li, Bin and Liu, Long and Gong, Ye and Bian, Jinjun and Li, Xiang and Tang, Yan and Lei, Ming and Chen, Dechang
The Journal of infectious diseases, ISSN 0022-1899, 04/2020, Volume 221, Issue Suppl 2, pp. S156 - S163
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Multivariate Analysis | Klebsiella pneumoniae - drug effects | Humans | Middle Aged | Male | beta-Lactamases - genetics | Escherichia coli - pathogenicity | Female | Retrospective Studies | Cross Infection - epidemiology | Hospital Mortality | Gram-Negative Bacteria | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Risk Factors | Bacterial Proteins - genetics | Enterobacteriaceae Infections - mortality | Logistic Models | China - epidemiology | Cross Infection - drug therapy | Intraabdominal Infections - mortality | Molecular Epidemiology | Klebsiella pneumoniae - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - pathogenicity | Aged | Anti-Bacterial Agents - pharmacology | Carbapenem-Resistant Enterobacteriaceae - drug effects | Intraabdominal Infections - drug therapy | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Acute infections and venous thromboembolism
by Schmidt, M and Horvath‐Puho, E and Thomsen, R. W and Smeeth, L and Sørensen, H. T
Journal of internal medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | General aspects | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Antibiotics. Antiinfectious agents. Antiparasitic agents | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies
by Heizmann, Wolfgang R and Dupont, Hervé and Montravers, Philippe and Guirao, Xavier and Eckmann, Christian and Bassetti, Matteo and SánchezGarcía, Miguel and Capparella, Maria Rita and Simoneau, Damien and Bodmann, Klaus Friedrich
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 07/2013, Volume 68, Issue 2, pp. ii45 - ii55
Complicated skin and soft-tissue infections | Complicated intra-abdominal infections | Non-interventional studies | Broad-spectrum antibacterial therapy | Polymicrobial infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Minocycline - pharmacology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Male | Skin Diseases, Bacterial - drug therapy | Gram-Negative Bacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Minocycline - therapeutic use | Aged, 80 and over | Adult | Female | Soft Tissue Infections - drug therapy | Bacterial Infections - microbiology | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Europe | Treatment Outcome | Soft Tissue Infections - epidemiology | Intraabdominal Infections - epidemiology | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Soft Tissue Infections - microbiology | Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Aged | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Pathogens | Effectiveness | Antibiotics | Antimicrobial agents | Drug resistance | Drug therapy | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
by Carmeli, Yehuda, Prof and Armstrong, Jon, MSc and Laud, Peter J, MSc and Newell, Paul, MBBS and Stone, Greg, PhD and Wardman, Angela, BPharm and Gasink, Leanne B, MD
The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Intraabdominal Infections - microbiology | Azabicyclo Compounds - administration & dosage | Humans | Middle Aged | Male | beta-Lactamase Inhibitors - administration & dosage | Pseudomonas aeruginosa - drug effects | Urinary Tract Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Carbapenems - therapeutic use | Drug Resistance, Multiple, Bacterial | beta-Lactamase Inhibitors - therapeutic use | Ceftazidime - administration & dosage | Enterobacteriaceae - drug effects | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Aged | Ceftazidime - adverse effects | Intraabdominal Infections - drug therapy | Azabicyclo Compounds - adverse effects | Medical research | Drug resistance in microorganisms | Care and treatment | Abscess | Medicine, Experimental | Urinary tract infections | Health aspects | Epidemiology | Ceftazidime | Abdomen | Pseudomonas aeruginosa | Studies | Pneumonia | Berries | Antibiotics | Infections | Drug resistance | Urogenital system | Urinary tract diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights